Eventide Asset Management’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-621,850	Closed	-$12.8M	–	159
2023 Q3	$12.8M	Buy	621,850 +308,443	+98%	+$6.36M	0.23%	112
2023 Q2	$9.25M	Hold	313,407	–	–	0.16%	121
2023 Q1	$7.22M	Buy	+313,407	New	+$7.22M	0.13%	122